Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

SHEN Liru, LI Ruihong, WANG Tailiang. Simultaneous determination of peimine and peiminine in Xiaoer Baotaikang granules by HPLC-ELSD[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(4): 351-353. doi: 10.3969/j.issn.1006-0111.2016.04.017
Citation: WEI Zhongming, MO Donghai, HUANG Qibin, DING Xueying. Gemcitabine hydrochloride thermosensitive gel injection preparation and contents determination[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(1): 36-40. doi: 10.3969/j.issn.1006-0111.2016.01.010

Gemcitabine hydrochloride thermosensitive gel injection preparation and contents determination

doi: 10.3969/j.issn.1006-0111.2016.01.010
  • Received Date: 2014-09-12
  • Rev Recd Date: 2015-07-09
  • Objective To prepare gemcitabine hydrochloride thermosensitive gel injection and to stablish the determination methods of its contents. Methods Gemcitabine hydrochloride thermosensitive gel injection was prepared using PLGA-PEG-PLGA as thermosensitive viecle. The contents of gemcitabine hydrochloride were determined by HPLC. Results The formulation contained 40 mg/ml gemcitabine and 20% (wt) PLGA-PEG-PLGA with phase-transition temperature of (37±0.15) ℃, showing the best viscosity around human body temperature. Gemcitabine hydrochloride presented a good linearity in the range of 5-500 μg/ml(r=0.999 8), which had good precision and reproducibility. The recovery rate of low, middle and high concentrations of gemcitabine hydrochloride were (99.5±3.2)%, (100.4±2.4)%, (102.1±2.4)%,n=3, respectively. The average contents of gemcitabine hydrochloride in three batches of sample were (101.87±2.95)%, (99.4±2.73)%, (98.98±0.71)%, n=3, respectively. Conclusion The quality of gemcitabine hydrochloride thermosensitive gel injection with PLGA-PEG-PLGA as matrix could be controlled. It is a promising new drug for pancreatic cancer.
  • [1] Cascium S, Craziano F, Catalana G. Chemotherapy for ad-vanced pancreatic cancer: It may no longer be ignored [J]. Ann Oncol,1999,10(1):105.
    [2] Saif MW.A new developments in the treatment of pancreatic cancer[J]. Highlights from the “ 44th ASCO Annual Meet-ing”.Chicago,IL,USA.May 30-June 3,2008.JOP 2008, 9:391-397.
    [3] Tanaka M,Javle M,Dong X, et al.Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients locally pancreatic cancer [J]. Cancer,2010,116(22):5325-5335.
    [4] Vervenne W,Bennouna J,Humblet Y,et al.A randomized, double blind,placebo controlled multicenter phase III trial to evaluate the efficacy and safety of adding bevacizumab to erlo-tinib and gemcitabine in patients with metastatic pancreatic cancer[J].J Clin Oncol,2008,26(suppl):4507.
    [5] Okino H, Maeyama R, Manabe T. Trans-tissue, sustained release of gemcitabine from photo cured gelatin gel inhibits the growth of heterotopic human pancreatic tumor in nude mice[J].Cli Cancer Res.2003,9 (15):5786-5793.
    [6] Rosemurgy AS,Serafini FM. New directions in systemic therapy of pancreatic cancer [J]. Cancer Control, 2000,7 (5):437-51.
    [7] Howell SB.Clinical applications of a novel sustained-release injectable drug delivery system: DepoFoamTM technology[J].Cancer J 2001,7(3):219-227.
    [8] Kim YJ, Kim SW. Controlled drug delivery from injectable biodegradable triblock copolymer [M]. Washington:Ameri-can Chemical Society,2003:300-311.
    [9] Jeong B,Bae YH.Biodegradable block copolymers as inject-able drug-delivery systems [J]. Nature,1997, 388 (6645): 860-862.
    [10] 杨 梅,李井泉,汤致强。PLGA 吉西他滨缓释微球在荷胰腺 癌裸鼠体内的药动学研究[J].中国药学杂志,2010,45 (4): 295-299.
  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-032025-0400.511.522.5Highcharts.com
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 87.2 %FULLTEXT: 87.2 %META: 11.0 %META: 11.0 %PDF: 1.8 %PDF: 1.8 %FULLTEXTMETAPDFHighcharts.com
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 25.0 %其他: 25.0 %其他: 0.3 %其他: 0.3 %Canada: 0.1 %Canada: 0.1 %China: 1.3 %China: 1.3 %Neptune City: 0.3 %Neptune City: 0.3 %United States: 0.5 %United States: 0.5 %[]: 0.8 %[]: 0.8 %上海: 3.4 %上海: 3.4 %中卫: 0.1 %中卫: 0.1 %临汾: 0.3 %临汾: 0.3 %临沂: 0.5 %临沂: 0.5 %兰州: 0.3 %兰州: 0.3 %北京: 13.8 %北京: 13.8 %南宁: 0.4 %南宁: 0.4 %南昌: 0.1 %南昌: 0.1 %厦门: 0.1 %厦门: 0.1 %台州: 0.1 %台州: 0.1 %呼和浩特: 0.1 %呼和浩特: 0.1 %哈尔滨: 0.3 %哈尔滨: 0.3 %宁波: 0.3 %宁波: 0.3 %巴音郭楞: 0.1 %巴音郭楞: 0.1 %广安: 0.1 %广安: 0.1 %广州: 0.3 %广州: 0.3 %张家口: 0.4 %张家口: 0.4 %徐州: 0.1 %徐州: 0.1 %恩施: 0.1 %恩施: 0.1 %成都: 0.1 %成都: 0.1 %昆明: 0.1 %昆明: 0.1 %普洱: 0.1 %普洱: 0.1 %杭州: 1.2 %杭州: 1.2 %枣庄: 0.3 %枣庄: 0.3 %桂林: 0.3 %桂林: 0.3 %梅州: 0.1 %梅州: 0.1 %榆林: 0.1 %榆林: 0.1 %武汉: 0.3 %武汉: 0.3 %沈阳: 0.1 %沈阳: 0.1 %泰安: 0.1 %泰安: 0.1 %济南: 0.1 %济南: 0.1 %济宁: 0.1 %济宁: 0.1 %深圳: 0.3 %深圳: 0.3 %漯河: 0.1 %漯河: 0.1 %百色: 0.1 %百色: 0.1 %盐城: 0.3 %盐城: 0.3 %石家庄: 0.9 %石家庄: 0.9 %芒廷维尤: 26.9 %芒廷维尤: 26.9 %芝加哥: 0.1 %芝加哥: 0.1 %衢州: 0.1 %衢州: 0.1 %西宁: 14.5 %西宁: 14.5 %西安: 0.1 %西安: 0.1 %达尔斯: 0.1 %达尔斯: 0.1 %运城: 0.5 %运城: 0.5 %遵义: 0.1 %遵义: 0.1 %郑州: 0.9 %郑州: 0.9 %重庆: 0.3 %重庆: 0.3 %长沙: 0.9 %长沙: 0.9 %长治: 0.1 %长治: 0.1 %防城港: 0.1 %防城港: 0.1 %阳泉: 0.1 %阳泉: 0.1 %青岛: 0.1 %青岛: 0.1 %黄冈: 0.8 %黄冈: 0.8 %黔东南: 0.1 %黔东南: 0.1 %其他其他CanadaChinaNeptune CityUnited States[]上海中卫临汾临沂兰州北京南宁南昌厦门台州呼和浩特哈尔滨宁波巴音郭楞广安广州张家口徐州恩施成都昆明普洱杭州枣庄桂林梅州榆林武汉沈阳泰安济南济宁深圳漯河百色盐城石家庄芒廷维尤芝加哥衢州西宁西安达尔斯运城遵义郑州重庆长沙长治防城港阳泉青岛黄冈黔东南Highcharts.com
  • Cited by

    Periodical cited type(4)

    1. 杨雅婷,吕晓君,张菊,徐小玲,何开勇,沈佳特. 氟马西尼原料药中细菌内毒素检查. 医药导报. 2024(09): 1470-1476 .
    2. 邝昆合,郑德志,江进红,李显立. 氟马西尼用于静吸复合全麻术后催醒的临床效果观察. 中国实用医药. 2023(09): 116-119 .
    3. 张宗鹏,王治国,石庆学,张国旭,霍花. 不同比活度~(11)C-氟马西尼体内代谢的差异分析. 药学实践杂志. 2020(04): 318-321 .
    4. 侯成,卢光照,鲁莹,董腾腾,邹豪. 军事人员对抗睡眠剥夺策略的研究进展. 第二军医大学学报. 2020(09): 1012-1020 .

    Other cited types(1)

通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(4045) PDF downloads(118) Cited by(5)

Related
Proportional views

Gemcitabine hydrochloride thermosensitive gel injection preparation and contents determination

doi: 10.3969/j.issn.1006-0111.2016.01.010

Abstract: Objective To prepare gemcitabine hydrochloride thermosensitive gel injection and to stablish the determination methods of its contents. Methods Gemcitabine hydrochloride thermosensitive gel injection was prepared using PLGA-PEG-PLGA as thermosensitive viecle. The contents of gemcitabine hydrochloride were determined by HPLC. Results The formulation contained 40 mg/ml gemcitabine and 20% (wt) PLGA-PEG-PLGA with phase-transition temperature of (37±0.15) ℃, showing the best viscosity around human body temperature. Gemcitabine hydrochloride presented a good linearity in the range of 5-500 μg/ml(r=0.999 8), which had good precision and reproducibility. The recovery rate of low, middle and high concentrations of gemcitabine hydrochloride were (99.5±3.2)%, (100.4±2.4)%, (102.1±2.4)%,n=3, respectively. The average contents of gemcitabine hydrochloride in three batches of sample were (101.87±2.95)%, (99.4±2.73)%, (98.98±0.71)%, n=3, respectively. Conclusion The quality of gemcitabine hydrochloride thermosensitive gel injection with PLGA-PEG-PLGA as matrix could be controlled. It is a promising new drug for pancreatic cancer.

SHEN Liru, LI Ruihong, WANG Tailiang. Simultaneous determination of peimine and peiminine in Xiaoer Baotaikang granules by HPLC-ELSD[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(4): 351-353. doi: 10.3969/j.issn.1006-0111.2016.04.017
Citation: WEI Zhongming, MO Donghai, HUANG Qibin, DING Xueying. Gemcitabine hydrochloride thermosensitive gel injection preparation and contents determination[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(1): 36-40. doi: 10.3969/j.issn.1006-0111.2016.01.010
Reference (10)

Catalog

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return